ANSELL LIMITED (ANN)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ANN

ANN - ANSELL LIMITED

Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 2.27
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Ansell is an Australian manufacturer of protective industrial equipment and household and medical gloves. It is the remnant of Pacific Dunlop, once a mighty conglomerate that listed in 1985. The name was changed to Ansell in 2002.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$33.97

10 Sep
2025

-0.210

OPEN

$34.32

-0.61%

HIGH

$34.53

268,001

LOW

$33.95

TARGET
$34.068

-0.69 change from previous day

0.3% upside
OTHER COMPANIES IN THE SAME SECTOR
AIM . ASB . CUP . DGL . IMB . KPG . RDX . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
ANN: 1
Title FY26
Forecast
FY27
Forecast
EPS (cps) 209.6 xxx
DPS (cps) 91.9 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 16.0 xxx
Dividend Yield 2.7% xxx
Div Pay Ratio(%) 43.8% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

N/A

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx108.0
DPS All xxxxxxxxxxxxxxx77.7
Sales/Revenue xxxxxxxxxxxxxxx3,093.3 M
Book Value Per Share xxxxxxxxxxxxxxx2,053.0
Net Operating Cash Flow xxxxxxxxxxxxxxx306.2 M
Net Profit Margin xxxxxxxxxxxxxxx5.07 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx5.38 %
Return on Invested Capital xxxxxxxxxxxxxxx3.87 %
Return on Assets xxxxxxxxxxxxxxx3.16 %
Return on Equity xxxxxxxxxxxxxxx5.38 %
Return on Total Capital xxxxxxxxxxxxxxx10.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx100.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx124 M
Long Term Debt xxxxxxxxxxxxxxx1,106 M
Total Debt xxxxxxxxxxxxxxx1,229 M
Goodwill - Gross xxxxxxxxxxxxxxx2,253 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx364 M
Price To Book Value xxxxxxxxxxxxxxx1.48

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx107.0 M
Capex % of Sales xxxxxxxxxxxxxxx3.46 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,826 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx840 M
Research & Development xxxxxxxxxxxxxxx32 M
Investments - Total xxxxxxxxxxxxxxx6 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

26/08/2025

3

Equal-weight

$32.50

-4.33%

Ansell posted FY25 EPS of US$1.26, up 23% year-on-year and 2% above consensus, with EBIT rising 44% to US$282m and group margins improving to 14.1%, highlights Morgan Stanley.

The broker explains weaker-than-expected revenue was offset by better-than-expected margins (Industrial Global Business Unit ahead).

Kimberly Clark synergies have been upgraded to US$15m, while a US$200m buy-back is planned for FY26. Tariff impacts of around -US$80m are expected to be fully offset by higher pricing.

The analysts see modest organic assumptions implied within FY26 guidance. Management guided to FY26 EPS of US$1.33-1.45, underpinned by 2-4% revenue growth and EBIT of US$302-325m at margins of 14.3-14.8%.

Risks include weaker industrial demand and cost pressures, suggests the broker, while upside could stem from further synergies.

Equal-weight rating. Target $32.50. Industry View: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 91.49 cents and EPS of 203.13 cents.
Morgan Stanley forecasts a full year FY27 EPS of 213.99 cents.

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

ANN STOCK CHART